Biogen completes acquisition of Apellis Pharmaceuticals - Ophthalmology Times
HealthcareMerger
Biogen→Apellis Pharmaceuticals
May 18, 2026
Biogen — Acquisitions & M&A Deals
7 dealsTracking 7 M&A deals by Biogen.
Biogen completes $5.3B Apellis Pharmaceuticals acquisition
HealthcareNew YorkPlatform
Biogen→Apellis Pharmaceuticals
May 15, 2026
Biogen Completes Acquisition of Apellis Pharmaceuticals
HealthcareDelawareMerger
Biogen→Apellis Pharmaceuticals
May 14, 2026
T/A - BIOGEN INC. (0000875045) (Filed by) — SEC SC TO Filing
HealthcareMerger
Biogen→Apellis Pharmaceuticals
May 6, 2026
T/A - Apellis Pharmaceuticals, Inc. (0001492422) (Subject) — SEC SC TO Filing
HealthcareMassachusettsMerger
Biogen→Apellis Pharmaceuticals
May 6, 2026
T - Apellis Pharmaceuticals, Inc. (0001492422) (Subject) — SEC SC TO Filing
HealthcareMassachusettsMerger
Biogen→Apellis Pharmaceuticals
Apr 14, 2026
Biogen, on the heels of a $5.6B buyout, turns its sights to early-stage assets
HealthcareMassachusettsMerger
Biogen→Apellis Pharmaceuticals
Apr 1, 2026